CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside

O Humbert, C Samuelson… - British journal of …, 2021 - Wiley Online Library
Genome editing therapies represent a significant advancement in next‐generation,
precision medicine for the management of haematological diseases, and CRISPR/Cas9 has …
被引用次数：9 相关文章

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.

O Humbert, C Samuelson, HP Kiem - British Journal of …, 2020 - europepmc.org
Genome editing therapies represent a significant advancement in next-generation, precision
medicine for the management of haematological diseases, and CRISPR/Cas9 has to date …

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside

O Humbert, C Samuelson… - British journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Genome editing therapies represent a significant advancement in next-generation, precision
medicine for the management of haematological diseases, and CRISPR/Cas9 has to date …
[HTML] nih.gov

[HTML][HTML] CRISPR/Cas9 for the treatment of haematological diseases: A journey from bacteria to the bedside

O Humbert, C Samuelson, HP Kiem - British journal of …, 2021 - ncbi.nlm.nih.gov
Genome editing therapies represent a significant advancement in next-generation, precision
medicine for the management of haematological diseases, and CRISPR/Cas9 has to date …